Dermapharm Holding SE (DMP)
XETR
38.40
+0.25 (+0.66%)
Closed
Oct 9, 2026
Day's Range
38.1538.90
52 wk Range
32.2051.90
Financial Statements - DMP - Dermapharm Holding SE
Revenue
1.16B▼ 1.3%
Net Income
131.35M▲ 17.6%Net Margin 11.3%
EBITDA
326.58M▲ 2.0%
Free Cash Flow
187.03M▲ 14.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 1.16B | 1.18B | 1.13B | 1.02B | 942.91M | 793.82M |
| Cost of Goods | 382.05M | 413.69M | 416.19M | 363.94M | 322.21M | 330.34M |
| Gross Profit | 782.92M | 767.07M | 719.16M | 660.83M | 620.69M | 463.48M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 227.31M | 214.73M | 180.10M | 242.04M | 287.04M | 145.27M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 183.51M | 172M | 105.99M | 216.29M | 292.97M | 125.28M |
| Income Tax | 52.15M | 60.26M | 45.46M | 83.68M | 84.07M | 39.35M |
| Net Income | 131.35M | 111.73M | 60.53M | 132.61M | 208.90M | 85.92M |
| EPS Basic | 2.46 | 2.11 | 1.16 | 2.49 | 3.89 | 1.59 |
| EPS Diluted | 2.46 | 2.11 | 1.16 | 2.49 | 3.89 | 1.59 |
| Basic Shares Outstanding | 53.84M | 53.84M | 53.84M | 53.84M | 53.84M | 53.84M |
| Diluted Shares Outstanding | 53.84M | 53.84M | 53.84M | 53.84M | 53.84M | 53.84M |
| Ebit | 232.18M | 230.41M | 160.96M | 228.63M | 301.81M | 134.64M |
| Ebitda | 326.58M | 320.10M | 260.80M | 328.54M | 348.25M | 190.60M |
| Net Income Continuous Operations | 183.51M | 172M | 105.99M | 216.29M | 292.97M | 125.28M |
| Minority Interests | 1.06M | 2.05M | 1.83M | 1.61M | 679K | -100K |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
